Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
about
Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USABilateral visual outcomes and service utilization of patients treated for 3 years with ranibizumab for neovascular age-related macular degeneration.Ranibizumab for the treatment of wet AMD: a summary of real-world studies.The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care.Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK.Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia.Induced pluripotent stem cell-based therapy for age-related macular degeneration.
P2860
Q34325608-2585F893-1A05-469A-8E6E-92344E5A1034Q35711457-304DC88C-E5AB-4D5E-BCF0-CD4FCD729A21Q37702363-8D691E2A-89B6-4E83-A5CA-2E00ED42EBC7Q38592591-C2CCC0F1-97F0-43A2-8A7C-10DF8D7EA0AEQ39598982-2EE4F396-AD2F-4D1A-9AE9-C5F6384E4675Q44558337-EEB43D17-2873-4B79-A0C0-128E8061DE51Q47124190-F10E05A6-4491-479A-BD06-A1101F2F79D3Q48218214-A8C118E8-34F7-4C66-98D2-F8391DA00224
P2860
Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Which visual acuity measuremen ...... tion treated with ranibizumab?
@ast
Which visual acuity measuremen ...... tion treated with ranibizumab?
@en
type
label
Which visual acuity measuremen ...... tion treated with ranibizumab?
@ast
Which visual acuity measuremen ...... tion treated with ranibizumab?
@en
prefLabel
Which visual acuity measuremen ...... tion treated with ranibizumab?
@ast
Which visual acuity measuremen ...... tion treated with ranibizumab?
@en
P2093
P2860
P356
P1433
P1476
Which visual acuity measuremen ...... tion treated with ranibizumab?
@en
P2093
J N Kirkpatrick
P H J Donachie
P H Scanlon
R L Johnston
P2860
P2888
P356
10.1038/EYE.2012.225
P577
2012-11-23T00:00:00Z